Quantcast
Home / Opinion Digests / Business Law / No FCA Claim from ‘Off-Label’ Marketing (access required)

No FCA Claim from ‘Off-Label’ Marketing (access required)

A pharmaceutical company employee has not stated a claim under the False Claims Act with general allegations that the company’s marketing of its “off-label” prescriptions and unnecessarily high-dose prescriptions of the company’s Kapidex drug necessarily meant that false claims for reimbursement had been submitted to federally sponsored health care plans; the 4th Circuit affirms dismissal ...

Print, Digital & Mobile

1 Month
$39

----------
6 Months
$199

----------
1 Year
$269

----------
2 Years
$659

----------
Digital & Mobile Only

1 Year
$299

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 

Scroll To Top